11th Annual ONCOLOGY ECONOMICS SUMMIT ____________________________________________________________________ Healthcare Reform and Access Issues Impacting Cancer Care in 2015 February 18 & 19, 2015 Hyatt Regency La Jolla l San Diego, CA AGENDA Day One - Wednesday, February 18, 2015 _______________________________________________________________________________________________ 7:30 Registration Check-In / Breakfast _______________________________________________________________________________________________ 8:30 Welcome & Opening Remarks Dean H. Gesme, Jr., MD, FASCO, FACP, FACPE Medical Oncologist & President Minnesota Oncology 8:45 Addressing Patient Access to Quality Cancer Care in 2015 and the Evolving Role of Integrated Delivery Networks in the New ACA Environment Linda Bosserman, MD, FACP Medical Oncologist City of Hope 9:30 Legislative Policy Update: Impact of Physician Payment Reform and SGR Legislation CMS Policy Trends: Sequestration, CMS Fee Schedule Changes, Medicare Part D Update Joseph Bailes, MD Medical Oncologist and National Authority on Healthcare Policy _______________________________________________________________________________________________ 10:00 Morning Break _______________________________________________________________________________________________ 10:30 Payment Reform: Examining the Impact of Health Insurance Reforms and Delivery System Reforms on the Oncology Marketplace Angela Lively Senior Vice President ADVI 11:15 Panel Discussion: Healthcare Reform and the Impact on Cancer Care Delivery _______________________________________________________________________________________________ 12:00 Luncheon _______________________________________________________________________________________________ www.conferagroup.com Tel/ 704-849-6934 th 11 Annual ONCOLOGY ECONOMICS SUMMIT AGENDA – Day One continued Wednesday, February 18, 2015 1:15 Evolving Impact of the ACA on the Oncology Practice and the Importance of Provider and Payer Collaborations Burton Vanderlaan, MD Medical Director Priority Health 2:00 The Impact of Clinical Pathways on the Delivery of High-Quality, Evidence-Based Care in the Oncology Community Practice Setting Michael Seiden, MD, PhD Senior Vice President and Chief Medical Officer McKesson Specialty Health / US Oncology Network ____________________________________________________________________________________ 2:45 Afternoon Break _______________________________________________________________________ 3:15 The Expanding Oral Oncology Drug Marketplace: Issues & Trends Impacting Access John Liu Executive Director, Reimbursement and Market Access Strategy Astellas 4:00 Examining New Oncology Distribution Channels and the Integrated Role of Specialty Pharmacy Matt Farber Senior Director of the Oncology Disease State Walgreens 4:30 Panel Discussion: The Current Status of the Oncology Practice and Implications for the Oncology Marketplace Burton Vanderlaan, MD Medical Director Priority Health Michael Seiden, MD, PhD Senior Vice President and Chief Medical Officer McKesson Specialty Health / US Oncology Network John Liu Executive Director, Reimbursement and Market Access Strategy Astellas Matt Farber Senior Director of the Oncology Disease State Walgreens 5:00 Summit Concludes for Day One ________________________________________________________________________________ 5:00- 6:30 Faculty & Attendee Reception _______________________________________________________________________________________________ www.conferagroup.com Tel/ 704-849-6934 11th Annual ONCOLOGY ECONOMICS SUMMIT AGENDA – Day Two Thursday, February 19, 2015 _________________________________________________________________________________________ 7:30 Breakfast _______________________________________________________________________________________________ 8:30 Opening Remarks and Review of Day One Joseph S. Bailes, MD Medical Oncologist and National Authority on Healthcare Policy 8:35 Examining Payer Considerations for Payment Reform Initiatives in Oncology: Bundled Payments, Oncology Medical Home, Pathway Compliance Michael Kolodziej, MD, FACP National Medical Director, Oncology Solutions Aetna 9:15 U.S. Oncology Market Access: Issues & Trends Impacting Reimbursement and Pricing Lee Blansett Senior Principal IMS Health _______________________________________________________________________________________________ 10:00 Morning Break _______________________________________________________________________________________________ 10:30 Molecular Diagnostics – Implications of PAMA and Issues Impacting Coverage, Coding and Payment Kim Linthicum Vice President, Government Affairs Myriad Genetics 11:00 Payer Cost Management Trends in the Changing Oncology Practice Site-of-Care Arena Jennifer Malin, MD, PhD Medical Director, Oncology Solutions & Innovation Anthem 11:45 Closing Remarks 12:00 Summit Adjourns www.conferagroup.com Tel/ 704-849-6934